Aulos Bioscience Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Aulos Bioscience is a California-based biotechnology company focused on immuno-oncology, developing therapeutics that steer a patient’s own IL-2–driven immune response toward tumor cells. Its lead candidate, AU-007, is designed to amplify anti-tumor activity while mitigating the toxicities associated with IL-2 therapies. The work blends advanced design concepts with immunology to pursue treatments for solid tumors.

Founded by Biolojic Design and ATP, the company operates in the biotechnology and cancer immunotherapy space, targeting solid tumors with IL-2–binding monoclonal antibodies. Recent developments include a Phase 2 data presentation for AU-007 in melanoma at the AACR Annual Meeting in 2025, reflecting progressing clinical activity. The organization is small and headquartered in Larkspur, California, pursuing its science with a focused team.

Sign up for free to view info

Company overview Employee directory